Quest Diagnostics (NYSE:DGX), a leading player in the field of diagnostic testing, has expanded its portfolio with a new test to help physicians determine whether a thyroid gland is cancerous and requires surgical removal. This test would help in thyroid biopsy testing and prevent unnecessary removal of healthy thyroids in many patients.  
Currently in use cytology test methods often lead to indeterminate results in the detection of cancer. As per estimates, approximately 54,500 new cases of … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards